Jonathan B. Siegel - 14 Aug 2023 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Lisa A. Conte, Attorney-in-Fact
Issuer symbol
JAGX
Transactions as of
14 Aug 2023
Net transactions value
$0
Form type
4
Filing time
14 Aug 2023, 17:53:36 UTC
Previous filing
19 May 2023
Next filing
10 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAGX Common Stock Award $0 +68,568 +5250% $0.000000 69,874 14 Aug 2023 Direct
holding JAGX Common Stock 59 14 Aug 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities held directly by JBS Healthcare Ventures LLC. Mr. Siegel, by virtue of his position as the sole member of JBS Healthcare Ventures LLC, may be deemed to beneficially own the securities held by JBS Healthcare Ventures LLC for purposes of Section 16.